Agios Pharmaceuticals, Inc.
AGIO
$33.58
$0.993.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -411.29M | -422.60M | -412.78M | -401.27M | 650.08M |
| Total Depreciation and Amortization | 5.35M | 5.26M | 5.18M | 5.28M | 5.25M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.98M | 72.27M | 67.67M | 60.77M | -1.03B |
| Change in Net Operating Assets | -44.65M | -35.34M | -33.04M | -74.71M | -29.13M |
| Cash from Operations | -360.60M | -380.41M | -372.98M | -409.93M | -406.00M |
| Capital Expenditure | -4.66M | -4.32M | -4.32M | -4.16M | -3.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 0.00 | 200.00M |
| Other Investing Activities | 371.81M | 410.23M | 381.50M | 242.11M | 196.22M |
| Cash from Investing | 367.15M | 405.91M | 377.18M | 237.95M | 393.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.22M | 9.14M | 8.68M | 10.96M | 9.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.22M | 9.14M | 8.68M | 10.96M | 9.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.78M | 34.64M | 12.88M | -161.02M | -3.65M |